MarketInOut Stock Screener Log In | Sign Up
 

Mustang Bio Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Mustang Bio Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2.8 mln
Float6.44 mln
Earnings Date11/06/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

29 / 100
Underperforming

ROE

-39.56
Deeply negative

ROA

-18.45
Deeply negative

Business Description

Mustang Bio is a US-based clinical-stage company working to turn advanced cell therapies into treatments for hard-to-treat cancers and autoimmune conditions. Founded in 2015 and based in Waltham, Massachusetts, the company has several therapies in development and clinical testing, including treatments targeting blood cancers, brain tumors, and autoimmune diseases. Mustang Bio works under licensing agreements with City of Hope National Medical Center and Nationwide Children's Hospital to advance its research.

Key Fundamentals

EPS-0.44
ROE-39.56
ROIC-2,730
ROA-18.45
EBITDA, mln-3.03
EV / EBITDA4.03
EV / EBIT4.03

Quote Details

Last 0.37
Change 0.0008 (0.22%)
Open 0.39
Volume 17,640
Turnover 6,526.8
Average Volume 38,445

Financial Ratios

Leverage Ratio2.07
Current Ratio1.97
Price / Book0.46
Price / Tangible Book0.46

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio1.96
Short % of Float0.78

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.7% 29 / 100   
1 Month -29.68% 12 / 100   
2 Months -43.25% 10 / 100   
6 Months -50.93% 12 / 100   
1 Year -74.83% 10 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog